Black Tusk Research Group

Black Tusk Research Group specializes in managing and operating clinical trials for hospital investigators and sponsors. They have supported over 45 principal investigators and managed more than 200 pharmaceutical and academic trials across multiple therapeutic areas. Their focus includes both project-specific tasks and full-scale project management for multi-center national or international studies[1][4][5].

The company partners with over ten pharmaceutical sponsors to facilitate efficient, cost-effective research while maintaining high standards of patient care[1][5]. No direct clinical results are reported as they do not sponsor their own investigational products.

Their team consists of approximately forty professionals with diverse backgrounds in medicine, research coordination, regulatory affairs, and data management[1][4].

Key leadership includes CEO Lynda Lazosky (founder) and co-founder Dr. John Boyd.

The company emphasizes professional integrity, streamlined processes for trial execution, patient-centered care, regulatory compliance support, data collection enhancement, patient recruitment optimization, and multi-site trial management[5][6].

They serve the pharmaceutical industry as well as academic medical centers.

There are no public reports of acquisition or closure; the company remains active as of June 2025.